Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2012, Article ID 746098, 4 pages
http://dx.doi.org/10.1155/2012/746098
Case Report

Primary Burkitt Lymphoma of the Chest Wall

Department of Pathology & Laboratory Medicine and Department of Medicine, Division of Hematology-Oncology, University of North Carolina at Chapel Hill, CB # 7600, Chapel Hill, NC 27599, USA

Received 9 December 2011; Accepted 19 January 2012

Academic Editors: R. Lowenthal and S. Storti

Copyright © 2012 Rommel Lu. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. U. Tateishi, G. W. Gladish, M. Kusumoto et al., “Chest wall tumors: radiologic findings and pathologic correlation—part 2. Malignant tumors,” Radiographics, vol. 23, no. 6, pp. 1491–1508, 2003. View at Google Scholar · View at Scopus
  2. G. R. Lanham, S. W. Weiss, and F. M. Enzinger, “Malignant lymphoma. A study of 75 cases presenting in soft tissue,” American Journal of Surgical Pathology, vol. 13, no. 1, pp. 1–10, 1989. View at Google Scholar · View at Scopus
  3. C. S. Cho, N. Blank, and R. A. Castellino, “Computerized tomography evaluation of chest wall involvement in lymphoma,” Cancer, vol. 55, no. 9, pp. 1892–1894, 1985. View at Google Scholar · View at Scopus
  4. K. A. Blum, G. Lozanski, and J. C. Byrd, “Adult Burkitt leukemia and lymphoma,” Blood, vol. 104, no. 10, pp. 3009–3020, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. D. R. Berk, A. Cheng, A. C. Lind, and S. J. Bayliss, “Burkitt lymphoma with cutaneous involvement,” Dermatology Online Journal, vol. 14, no. 2, article 14, 2008. View at Google Scholar · View at Scopus
  6. M. A. Jacobson, A. C. S. Hutcheson, D. H. Hurray, J. S. Metcalf, and B. H. Thiers, “Cutaneous involvement by Burkitt lymphoma,” Journal of the American Academy of Dermatology, vol. 54, no. 6, pp. 1111–1113, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. C. Bachmeyer, A. Bazarbachi, B. Rio et al., “Specific cutaneous involvement indicating relapse of Burkitt's lymphoma,” American Journal of Hematology, vol. 54, no. 2, p. 176, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. R. García-Barredo, M. A. Fernández Echevarría, M. Del Riego, and A. Canga, “Soft tissue Burkitt's lymphoma: radiological findings,” European Radiology, vol. 8, no. 9, pp. 1654–1656, 1998. View at Google Scholar · View at Scopus
  9. N. Yaris, M. Cakir, A. Ahmetoglu, and S. Ersoz, “Primary Burkitt's lymphoma only involving the chest wall at relapse in a child,” Leukemia and Lymphoma, vol. 45, no. 4, pp. 837–839, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. L. Leoncini, M. Raphäel, and H. Stein, “Burkitt lymphoma,” in WHO Classification of Tumours and Haematopoietic and Lymphoid Tissues, S. H. Swerdlow, E. Campo, N. L. Harris et al., Eds., pp. 262–264, IARC, Lyon, France, 4th edition, 2008. View at Google Scholar
  11. C. Soussain, C. Patte, M. Ostronoff et al., “Small noncleaved cell lymphoma and leukemia in adults. A retrospective study of 65 adults treated with the LMB pediatric protocols,” Blood, vol. 85, no. 3, pp. 664–674, 1995. View at Google Scholar · View at Scopus
  12. A. Reiter, M. Schrappe, W. D. Ludwig et al., “Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: a report of three consecutive studies of the BFM group,” Blood, vol. 80, no. 10, pp. 2471–2478, 1992. View at Google Scholar · View at Scopus
  13. I. Magrath, M. Adde, A. Shad et al., “Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen,” Journal of Clinical Oncology, vol. 14, no. 3, pp. 925–934, 1996. View at Google Scholar · View at Scopus
  14. J. I. Bernstein, C. N. Coleman, and J. G. Strickler, “Combined modality therapy for adults with small noncleaved cell lymphoma (Burkitt's and non-Burkitt's types),” Journal of Clinical Oncology, vol. 4, no. 6, pp. 847–858, 1986. View at Google Scholar
  15. D. A. Thomas, J. Cortes, S. O'Brien et al., “Hyper-CVAD program in Burkitt's-type adult acute lymphoblastic leukemia,” Journal of Clinical Oncology, vol. 17, no. 8, pp. 2461–2470, 1999. View at Google Scholar · View at Scopus
  16. E. J. Lee, G. R. Petroni, C. A. Schiffer et al., “Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of Cancer and Leukemia Group B Study 9251,” Journal of Clinical Oncology, vol. 19, no. 20, pp. 4014–4022, 2001. View at Google Scholar · View at Scopus
  17. S. Smeland, A. K. Blystad, S. O. Kvaløy et al., “Treatment of Burkitt's/Burkitt-like lymphoma in adolescents and adults: a 20-year experience from the norwegian radium hospital with the use of three successive regimens,” Annals of Oncology, vol. 15, no. 7, pp. 1072–1078, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. M. Cabanillas, D. Thomas, J. Cortes et al., “Outcome with hyper-CVAD and rituximab in Burkitt (BL) and Burkitt-like (BLL) leukemia/lymphoma,” Proceedings of the American Society of Clinical Oncology, vol. 22, abstract 2309, 2003. View at Google Scholar
  19. M. L. McMaster, J. P. Greer, F. A. Greco, D. H. Johnson, S. N. Wolff, and J. D. Hainsworth, “Effective treatment of small-noncleaved-cell lymphoma with high-intensity, brief-duration chemotherapy,” Journal of Clinical Oncology, vol. 9, no. 6, pp. 941–946, 1991. View at Google Scholar · View at Scopus